|
|
||
|
|
||
| General information | Expression | Regulation | Mutation | Interaction |
Basic Information | |
|---|---|
Gene ID | 3732 |
Name | CD82 |
Synonymous | 4F9|C33|GR15|IA4|KAI1|R2|SAR2|ST6|TSPAN27;CD82 molecule;CD82;CD82 molecule |
Definition | C33 antigen|CD82 antigen|inducible membrane protein R2|kangai 1 (suppression of tumorigenicity 6, prostate; CD82 antigen (R2 leukocyte antigen, antigen detected by monoclonal and antibody IA4))|metastasis suppressor Kangai-1|tetraspanin-27|tspan-27 |
Position | 11p11.2 |
Gene Type | protein-coding |
Gene Regulation: | Transcription Factors Post Transcriptional Modification From dbPTM Methylation Profile From DiseaseMeth database |
Transcription Factors | | Top | |
Regulation From TransFac database | vangl1(h) + KAI1(h) <==> vangl1(h):KAI1(h) (binding) | CD82(h) --> KAI1(h) (expression). | KAI1(h) --> KAI1(h) (translocation) | KAI1(h) + vangl1-isoform1(h) <==> KAI1(h):vangl1-isoform1(h) (binding) | CD82(h) --> KAI1(h) (expression). | KAI1(h) --> KAI1(h) (translocation) | Chfr(h) --> KAI1(h) (increase of abundance) |
|---|
Post Transcriptional Modification From dbPTM | | Top | |
Location (AA) | PTM type | Literature | Database | 157 | N-linked (GlcNAc...) (Potential). | Swiss-Prot 53.0 | 198 | N-linked (GlcNAc...) (Potential). | Swiss-Prot 53.0 |
|---|
Methylation Profile From DiseaseMeth database | | Top | |
Chromosome | Location | Source |
|---|---|---|
chr11 |
Promoter: 44542217 - 44544217 | Agilent_014791 |
chr11 |
Promoter: 44542217 - 44544217 | GoldenGate_Methylation_Cancer_Panel_I |
chr11 |
Promoter: 44542217 - 44544217 | GoldenGate_Methylation_Cancer_Panel_I |
chr11 |
Promoter: 44542217 - 44544217 | GSE27584 |
chr11 |
Promoter: 44542217 - 44544217 | GSE27584 |
chr11 |
Promoter: 44542217 - 44544217 | Agilent_014791_44K |
chr11 |
Promoter: 44542217 - 44544217 | Agilent_014791 |